Nowadays the most important and informative way to follow-up new biotherapeutics based on antibodies and their biodistribution/metabolic routes in the living body is antibody linking. Antibodies can be followed in different ways including in vivo investigations. We believe that labeling longer biological half-life antibodies with long half-life isotopes for uniquely exact and quantitative PET (⁸⁹Zr) and SPECT (¹⁷⁷Lu, ¹¹¹In) imaging can give precise, fast, accurate answers in vivo. This leads up to 80% reduction of cost and animal number, and up to 50% increase in data robustness. We are using several tracers to label antibodies and follow their metabolic ways and targeting properties.

For our tracer catalog please Contact Us. For images please see our Image Gallery.